phs000228.v4.p1
HMP Core Microbiome Sampling Protocol A (HMP-A) | Versions 1-4: passed embargo
| VDAS | 300 | Population-Based Control Set | Links | 454 GS FLX Titanium
454 GS FLX Titanium
|
phs000018.v2.p1
Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants), GAIN | Versions 1-2: passed embargo
| VDAS | 1972 | Case-Control | Links | Mapping250K_Nsp
Mapping250K_Sty
|
phs000086.v3.p1
DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0
ILLUMINA_Human_1M
|
phs000088.v1.p1
Search for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes (GoKinD study participants and parents), NIDDK | Version 1: passed embargo
| VDAS | 1206 | Case-Control | Links | Mapping250K_Nsp
Mapping250K_Sty
|
phs000007.v30.p11
Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy
Mapping250K_Nsp
Mapping250K_Sty
Mapping50K_Hind240
Mapping50K_Xba240
|
phs000503.v6.p3
Women's Health Initiative Sight Examination (WHISE) | Versions 1-5: passed embargo
Version 6:
| VDAS | 3031 | Randomized, Double-Blind, Clinical Trial | Links | |
phs000833.v7.p1
Single Cell Analysis Program - Transcriptome (SCAP-T) | Versions 1-7: passed embargo
| VDAS | 215 | Case Set, Single Cell Analysis | Links | |
phs000200.v12.p3
Women's Health Initiative | Versions 1-11: passed embargo
Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs000096.v4.p1
HAPO Maternal Glycemia and Birthweight GEI Study | Versions 1-4: passed embargo
| VDAS | 9987 | Prospective, Observational, Cohort | Links | Human1M-Duov3_B
Human610_Quadv1_B
HumanOmni1-Quad_v1-0_B
|
phs001053.v1.p1
NEI Exfoliation Genotyping Study | Version 1: passed embargo
| VDAS | 1506 | Case Set, Parent-Offspring | Links | HumanHap550v3.0
Assembler Version 1.2.0; File Format Version: July 2009
HumanOmniExpressExome-8v1_A
|
phs000343.v3.p1
The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial | Versions 1-3: passed embargo
| VDAS | 2164 | Multicenter, Randomized, Clinical Trial, Double-Blind, Controlled Trial | | HumanOmni1-Quad_v1-0_B
|
phs000210.v1.p1
PGRN-RIKEN MA.27 Mayo Aromatase Inhibitor Musculoskeletal Adverse Events Study | Version 1: passed embargo
| VDAS | 879 | Nested Case-Control | Links | |
phs001496.v1.p1
A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics | Version 1: passed embargo
| VDAS | 115 | Case-Control | Links | DMET Plus
Ion PGM 200 Sequencing Kit v2
|
phs001327.v1.p1
Childhood Cancer Survivor Study (CCSS) | Version 1: passed embargo
| VDAS | 5739 | Cohort, Longitudinal | | Infinium HumanOmni5Exome-4 v1.0
|
phs000287.v6.p1
Cardiovascular Health Study (CHS) Cohort | Versions 1-6: passed embargo
| VDAS | 5609 | Longitudinal | | |
phs000095.v3.p1
Dental Caries GWAS | Versions 1-3: passed embargo
| VDAS | 5418 | Nuclear Families, Parent-Offspring Trios, Case-Control | | Human610_Quadv1_B
|
phs000594.v1.p1
A Phase 2 Study of Tipifarnib in Large Granular Lymphocyte (LGL) Leukemia | Version 1: passed embargo
| VDAS | 9 | Interventional, Clinical Trial | Links | |
phs001073.v1.p1
Epigenetic Analysis of Malnutrition | Version 1: passed embargo
| VDAS | 59 | Interventional, Randomized, Clinical Trial | | TruSeq ChIP
|
phs001288.v1.p1
Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC) | Version 1: passed embargo
| VDAS | 264 | Longitudinal | Links | |
phs000914.v1.p1
Genome-wide Association Study of Adiposity in Samoans | Version 1: passed embargo
| VDAS | 3501 | Cross-Sectional, Population | Links | AFFY_6.0
|